Kamada Ltd. — Director's Dealing 2026

Mar 21, 2026

E

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden hours per response	0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* London Amir			2. Date of Event Requiring Statement (Month/Day/Year) 03/16/2026	3. Issuer Name and Ticker or Trading Symbol KAMADA LTD [ KMDA ]
(Last)	(First)	(Middle)		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Chief Executive Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
15D YEKUTIEL ADAM ST.					6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting X Person Form filed by More than One Reporting Person
(Street) KFAR SABA L3 44282
(City)	(State)	(Zip)
Table I – Non-Derivative Securities Beneficially Owned
---	---	---	---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	61,875	D
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---	---	---	---	---
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase Ordinary Shares(1)	12/22/2023	06/22/2029	Ordinary Shares	100,000	$6.15(2)
Options to purchase Ordinary Shares(1)	12/22/2024	06/22/2029	Ordinary Shares	100,000	$6.15(2)
Options to purchase Ordinary Shares(1)	12/22/2025	06/22/2029	Ordinary Shares	100,000	$6.15(2)
Options to purchase Ordinary Shares(1)	12/10/2026	12/10/2035	Ordinary Shares	100,000	$7.55(2)
Options to purchase Ordinary Shares(1)	12/22/2026	06/22/2029	Ordinary Shares	100,000	$6.15(2)
Options to purchase Ordinary Shares(1)	12/10/2027	12/10/2035	Ordinary Shares	100,000	$7.55(2)
Options to purchase Ordinary Shares(1)	12/10/2028	12/10/2035	Ordinary Shares	100,000	$7.55(2)
Options to purchase Ordinary Shares(1)	12/10/2029	12/10/2035	Ordinary Shares	100,000	$7.55(2)

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

/s/ Amir London

** Signature of Reporting Person

03/16/2026

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

---

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.